Substrate
science

Woman's Arm Tumor Disappears After Biopsy, Leading to Remission Without Treatment

A 59-year-old woman's myxofibrosarcoma tumor vanished following a diagnostic biopsy, resulting in remission without further treatment. The case, one of nine known instances, suggests an immune response triggered by the procedure. Researchers published the findings on April 15, 2026, in Cureus: Journal of Medical Science.

New Scientist
1 source·May 5, 12:00 PM(21 hrs ago)·2m read
Woman's Arm Tumor Disappears After Biopsy, Leading to Remission Without TreatmentWikimedia Commons (CC BY-SA 2.5)
Audio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.

A 59-year-old woman's rapidly growing arm tumor disappeared after a biopsy, putting her into remission without any treatment, @NewScientist reported. The lump, identified as a myxofibrosarcoma in the connective tissue between her skin and muscle, contained aggressive cancer cells likely to spread.

This marks one of nine known cases where a biopsy led to the disappearance of such a tumor within a few weeks.

The woman noticed the lump a few weeks before seeking medical help, when it measured 2 centimeters wide and was progressing rapidly, causing pain and discomfort. Rohit Sharma at Marshfield Clinic Health System in Wisconsin treated her. Sharma and colleagues marked the tumor's location with tattoo ink and took a biopsy using a thin needle.

The biopsy revealed the aggressive nature of the myxofibrosarcoma. Two weeks later, the woman returned for surgery to remove the tumor, but clinicians discovered it had completely disappeared. After the biopsy, the tumor started to go down within three to four days, Sharma said.

The team surgically excised the tissue surrounding the tumor's former location, and analysis confirmed no cancer cells remained. 'The timing of the biopsy and resolution suggests there’s an immune reaction occurring,' said Rohit Sharma. The woman is now in remission despite receiving no treatment.

'It’s extremely remarkable,' said Toby Lawrence at the Centre for Immunology of Marseille-Luminy in France. 'It really suggests some kind of immune activation in response to the injury of the biopsy, because it had extremely rapid effects on tumour growth,' Lawrence added. The case was published on April 15, 2026, by Gannon M C, Gabor R M, Gupta A, et al.

107111. @NewScientist reported that such spontaneous resolutions after biopsy are highly unusual, particularly for connective tissue cancers. Sharma noted the tumor was likely to spread, emphasizing that cancers kill by spreading.

The woman's concern prompted her to seek help as the lump grew rapidly. An X-ray of the woman’s arm showed the tumor before the biopsy, with an arrow pointing to its location. A subsequent magnetic resonance imaging scan was also part of the documentation.

These imaging details supported the confirmation of the tumor's complete disappearance post-biopsy.

Key Facts

Tumor disappearance after biopsy
A 59-year-old woman's myxofibrosarcoma tumor vanished within weeks after a diagnostic biopsy, leading to remission without treatment.
Case rarity
This is one of nine known cases where a biopsy led to the disappearance of a myxofibrosarcoma tumor.
Immune response suggestion
Experts suggest the biopsy triggered an immune activation, with rapid effects on tumor growth.
Publication details
The case was published on April 15, 2026, in Cureus: Journal of Medical Science with DOI 10.7759/cureus.107111.

Story Timeline

5 events
  1. 2026-04-15

    The case was published by Gannon M C, Gabor R M, Gupta A, et al. in Cureus: Journal of Medical Science with DOI 10.7759/cureus.107111.

    1 source@NewScientist
  2. Two weeks after biopsy

    The woman returned for surgery, but the tumor had completely disappeared; team excised surrounding tissue confirming no cancer cells.

    1 source@NewScientist
  3. Three to four days after biopsy

    The tumor started to go down.

    1 source@NewScientist
  4. Biopsy date

    Sharma and colleagues marked the tumor with tattoo ink and took a biopsy using a thin needle, revealing myxofibrosarcoma.

    1 source@NewScientist
  5. A few weeks before seeking help

    The 59-year-old woman noticed a rapidly growing lump in her arm, which was 2 centimeters wide when she sought help.

    1 source@NewScientist

Potential Impact

  1. 01

    Potential for research into biopsy-induced immune responses to improve cancer therapies.

  2. 02

    Increased documentation of similar cases to build a database for further study.

  3. 03

    Insights into genetic and environmental factors enabling such immune reactions.

  4. 04

    Possible development of drugs mimicking the biopsy's effect on tumor visibility to the immune system.

Transparency Panel

Sources cross-referenced1
Confidence score75%
Synthesized bySubstrate AI
Word count355 words
PublishedMay 5, 2026, 12:00 PM
Bias signals removed3 across 3 outlets
Signal Breakdown
Loaded 2Speculative 1

Related Stories

Hantavirus Cases Reported on MV Hondius Cruise Ship, Three Fatalities Amid Low Transmission Riskdeccanchronicle.com
science9 hrs agoDeveloping

Hantavirus Cases Reported on MV Hondius Cruise Ship, Three Fatalities Amid Low Transmission Risk

A hantavirus outbreak on the MV Hondius cruise ship has killed three passengers and sickened seven others, prompting an international response coordinated by the World Health Organization. The ship, carrying 147 people from 23 nationalities, is set to sail to Spain's Canary Islan…

Stat
Cbs News
2 sources
Imperial College London Study Analyzes Changes in Wildfire Weather Patterns in Northern Irelandtechjuice.pk
science3 hrs agoDeveloping

Imperial College London Study Analyzes Changes in Wildfire Weather Patterns in Northern Ireland

A new report from Imperial College London highlights growing wildfire threats in Northern Ireland due to more favorable conditions, especially in spring. Researchers note increased drought and fire-prone weather, exacerbated by climate change. The findings point to longer fire se…

The Bbc
1 source
FDA Commissioner Defends Drug Rejection DecisionsThe U.S. Food and Drug Administration / Wikimedia (Public domain)
science15 hrs agoFraming55Framing risk55/100Lede misdirection foregrounds commissioner's defense over substantive drug rejections; inherited negative valence from sources on agency turmoil and backlash.Click to jump to full framing analysis

FDA Commissioner Defends Drug Rejection Decisions

The FDA commissioner defended recent drug rejections in a CNBC interview, citing adherence to scientific reviews amid reports of agency turmoil. Criticism includes a high-profile denial of a melanoma treatment from Replimune and pressure from President Trump over vape approvals.…

cnbc.com
Wall Street Journal
joemygod.com
3 sources